933796-16-8
933796-16-8
Chemical Structure
KD-027
Synonym(s): SLx-2101
- CAS No.: 933796-16-8
- Formula:C25H35N7O6S
- Molecular Weight:561.65
IUPAC Name: 2-(dimethylamino)-N-(N-((4-ethoxy-3-(5-methyl-4-oxo-7-propyl-1,4-dihydroimidazo[5,1-f][1,2,4]triazin-2-yl)phenyl)sulfonyl)-N-methylglycyl)-N-methylacetamide
InChIKey: KMBGDFWPWSDZTL-UHFFFAOYSA-N
SMILES: O=C1N=C(C2=C(OCC)C=CC(S(=O)(N(CC(N(CC(N(C)C)=O)C)=O)C)=O)=C2)NN3C1=C(C)N=C3CCC
Biological Activity: KD-027 (SLx-2101) is a Phosphodiesterase 5 (PDE5) inhibitor. KD-027 can be used for endothelial dysfunction, and hypertension research[1].
| Cat. No. | Nom du produit | Pureté | Description | Pricing | |||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
KD-027 | KD-027 (SLx-2101) is a Phosphodiesterase 5 (PDE5) inhibitor. KD-027 can be used for endothelial dysfunction, and hypertension research. | |||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
References
Keywords
